NCT01037881View on ClinicalTrials.gov

LEO 29102 Cream in the Treatment of Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

183

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Atopic Dermatitis
Interventions
DRUG

LEO 29102

comparison of different dosages of drug

DRUG

Elidel®

comparison

Trial Locations (3)

53105

Klinik und Poliklinik für Dermatologie, Universität Bonn, Bonn

N8W 5L7

Windsor Clinical Research Inc., Windsor

00250

Helsinki University Central Hospital, Helsinki

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY